Patents Assigned to Cyclacel Limted
  • Pyrimidine compounds
    Patent number: 7432260
    Abstract: The present invention relates to substituted pyrimidines of formula I, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders and/or viral disorders.
    Type: Grant
    Filed: November 17, 2004
    Date of Patent: October 7, 2008
    Assignee: Cyclacel Limted
    Inventors: Shudong Wang, Christopher Meades, Gavin Wood, Janice O'Boyle, Campbell McInnes, Peter Martin Fischer